A detailed history of Pathstone Family Office, LLC transactions in Seagen Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 3,780 shares of SGEN stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,780
Previous 3,298 14.61%
Holding current value
$0
Previous $634,000 26.34%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$191.51 - $216.16 $92,307 - $104,189
482 Added 14.61%
3,780 $801,000
Q2 2023

Jan 12, 2024

SELL
$187.64 - $206.25 $90,442 - $99,412
-482 Reduced 12.75%
3,298 $634,000
Q2 2023

Aug 14, 2023

SELL
$187.64 - $206.25 $56,104 - $61,668
-299 Reduced 8.31%
3,298 $634,000
Q1 2023

May 15, 2023

SELL
$127.59 - $203.08 $44,528 - $70,874
-349 Reduced 8.84%
3,597 $728,000
Q4 2022

Oct 23, 2023

BUY
$117.37 - $139.17 $15,492 - $18,370
132 Added 3.46%
3,946 $507,000
Q4 2022

Feb 13, 2023

SELL
$117.37 - $139.17 $4,577 - $5,427
-39 Reduced 0.98%
3,946 $507,000
Q3 2022

Oct 23, 2023

SELL
$135.27 - $180.11 $18,667 - $24,855
-138 Reduced 3.49%
3,814 $521,000
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $18,667 - $24,855
-138 Reduced 3.35%
3,985 $566,000
Q2 2022

Oct 23, 2023

BUY
$108.81 - $179.33 $71,161 - $117,281
654 Added 19.83%
3,952 $699,000
Q2 2022

Aug 15, 2022

BUY
$108.81 - $179.33 $164,847 - $271,684
1,515 Added 58.09%
4,123 $731,000
Q1 2022

May 16, 2022

BUY
$119.61 - $157.85 $57,891 - $76,399
484 Added 22.79%
2,608 $397,000
Q4 2021

Feb 14, 2022

BUY
$142.57 - $190.86 $33,503 - $44,852
235 Added 12.44%
2,124 $328,000
Q3 2021

Nov 16, 2021

BUY
$142.45 - $169.82 $44,586 - $53,153
313 Added 19.86%
1,889 $321,000
Q2 2021

Aug 31, 2021

BUY
$135.08 - $161.1 $11,887 - $14,176
88 Added 5.91%
1,576 $249,000
Q1 2021

May 14, 2021

BUY
$137.51 - $190.8 $180,413 - $250,329
1,312 Added 745.45%
1,488 $207,000
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $28,974 - $37,299
176 New
176 $31,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.